The HCPLive HIV/AIDS page is a comprehensive resource for clinical news and insights on human immunodeficiency virus. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for HIV, and more.
September 28th 2023
Results from the systematic review and meta-analysis showed FMT restored the normal microbiome, reduced the risk of gastrointestinal infections, and did not lead to increased adverse events in patients with HIV.
December 15th 2021
September 13th 2021
ART Impacts How HIV Establishes Itself in the Female Reproductive Tract
February 25th 2016The human immunodeficiency virus (HIV) is no longer the death sentence it was when the virus was first discovered in 1983. Although patients are living better, longer lives, finding a cure to the disease remains a top priority.
Charlie Sheen Reveals He's HIV-Positive, But His Doctor Says It Won't Kill Him
November 17th 2015Former Two and a Half Men star Charlie Sheen divulged on the TODAY show Tuesday morning that he is infected with HIV (human immunodeficiency virus). And while it can impact everyday life, it is not the be-all and end-all disease that it once was in the 80's.
The Social and Socioeconomic Benefits of HIV Treatment
August 21st 2015Findings from two studies presented July 22 at the International AIDS Society (IAS) Conference in Vancouver, Canada indicate that HIV treatment for illicit drug users appears to improve their social and socioeconomic wellbeing, in addition to their overall health.
HIV-Positive Transgender Women Going Without Medications, Basic Needs
June 23rd 2015Study results show transgender women living with HIV are less likely to adhere to anti-HIV medication regimens and achieve viral suppression rates, and are more likely than non-transgender men to be deprived of basic needs.
Broadly Neutralizing Antibody Suppresses HIV Infection
June 23rd 2015Researchers at Rockefeller University in New York City suggest that a member of a new generation of broadly neutralizing antibodies to HIV appears to reduce the viral load of patients with the infection and significantly reduce viremia through 28 days.
Diabetes Drug Addresses Inflammation in HIV Patients
May 22nd 2015Sitagliptin appears to have beneficial systemic and adipose anti-inflammatory effects in combination antiretroviral therapy-treated HIV-positive adults with impaired glucose tolerance. The drug may prevent cardiovascular problems by reducing inflammation linked to heart disease and stroke in this patient population.
Kidney Disease Risk Higher with Longer Exposure to Antiretrovirals, Study Finds
March 1st 2015Chronic kidney disease developed in association with exposure to antiretrovirals in people with initially normal levels of estimated glomerular filtration rate (eGFR) was not limited to increased incidence immediately after starting therapy but in fact increased over time and exposure.
New Formulation Compares Favorably to Current, Commonly Used Tenofovir Dose
March 1st 2015Tenofovir alafenamide, which results in 90% lower circulating plasma tenofovir than standard tenofovir disoproxil fumarate, is associated with similar virologic response rates as the standard regimen, but with an improved safety profile.
Lipodystrophy: What HAART Has Taught Us
February 25th 2015The most common causes of lipodystrophy are insulin injection, antiretroviral drugs, and hereditary disorders. Some patients with insulin-related lipodystrophy also develop metabolic dysfunction, including insulin resistance, elevated free fatty acids level, abnormal adipocytokine secretion, and ectopic fat deposition.